Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 28865670 | HLA-A (HLA-A) | hematopoietic stem cell transplantation | Chinese | NA | NA | unclassified | |
| better outcome for hematopoietic stem cell transplantation (hsct) requires optimal matching between donor and recipient at the hla-a, -b, -c, and -drb1 loci. | |||||||
| 28865670 | HLA-DRB1 (HLA-DRB1) | hematopoietic stem cell transplantation | Chinese | NA | NA | unclassified | |
| better outcome for hematopoietic stem cell transplantation (hsct) requires optimal matching between donor and recipient at the hla-a, -b, -c, and -drb1 loci. | |||||||
| 28987960 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | Norwegian | NA | NA | unclassified | |
| with available hla haplotype frequency information for the patient's ethnicity, our data allows upfront estimation of the probability that an hla-matched donor with ccr5-d32/d32 genotype can be found for a patient in need of hematopoietic stem cell transplantation. | |||||||
| 29032270 | HLA (HLA) | hematopoietic stem cell transplantation | German | NA | NA | only_studied | |
| in the last phase, the impact of specifically finnish-enriched hla haplotypes on finnish patients and the use of finnish registry donors was assessed by analyzing 647 consecutive hematopoietic stem cell transplantation (hsct) donor searches and 40 exported finnish hscts. | |||||||
| 29108995 | HLA-DR (HLA-DR) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| we previously shown that circulating hla-dr-cd14+ monocytic mdscs are a major contributor to clinical outcomes after allogeneic hematopoietic stem cell transplantation (allo-hsct). | |||||||
| 29120571 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | Latin American | NA | NA | unclassified | |
| hematopoietic stem cell transplantation from an hla-identical donor provides the best treatment option. | |||||||
| 29196075 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| currently, hematopoietic stem cell transplantation (hsct) is the most reliable curative treatment with excellent results for patients with hla-matched family or unrelated donors. | |||||||
| 29384898 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| in this report we reviewed the case of a pediatric patient who experienced ptld after allogeneic hematopoietic stem cell transplantation (hsct) from a human leukocyte antigen (hla)-identical sibling. | |||||||
| 29410546 | HLA-A (HLA-A) | hematopoietic stem cell transplantation | NA | NA | NA | negation | |
| for hematopoietic stem cell transplantation (hct) hla 10/10 (hla-a, b, c, drb1, dqb1) matched donors are optimal, but are not available for all patients. | |||||||
| 29410546 | HLA-DRB1 (HLA-DRB1) | hematopoietic stem cell transplantation | NA | NA | NA | negation | |
| for hematopoietic stem cell transplantation (hct) hla 10/10 (hla-a, b, c, drb1, dqb1) matched donors are optimal, but are not available for all patients. | |||||||
Copyright 2024